These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8769715)

  • 1. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
    Ogawa K; Tokusashi Y; Fukuda I
    Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
    Mangues R; Kahn JM; Seidman I; Pellicer A
    Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
    Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
    Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
    Haag JD; Hsu LC; Newton MA; Gould MN
    Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
    Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
    Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
    Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M
    Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
    McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
    Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
    Zhuang SM; Wiseman RW; Söderkvist P
    Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations.
    Imaoka T; Nishimura M; Kakinuma S; Hatano Y; Ohmachi Y; Yoshinaga S; Kawano A; Maekawa A; Shimada Y
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):194-203. PubMed ID: 17707273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased H-ras mutation frequency in mammary tumors of rats initiated with N-methyl-N-nitrosourea (MNU) and treated with acrylamide.
    Cho YM; Imai T; Hasumura M; Watanabe N; Ushijima T; Hirose M; Nishikawa A
    J Toxicol Sci; 2009 Oct; 34(4):407-12. PubMed ID: 19652463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland.
    Zhang R; Haag JD; Gould MN
    Cell Growth Differ; 1991 Jan; 2(1):1-6. PubMed ID: 2007094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein.
    Lee R; Woo W; Wu B; Kummer A; Duminy H; Xu Z
    Exp Biol Med (Maywood); 2003 Jun; 228(6):689-96. PubMed ID: 12773700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.